Abstract

BackgroundProbiotics have been demonstrated to ameliorate clinical signs of gastrointestinal diseases in dogs in various studies. However, the effect of probiotics in a healthy population, as well as factors contributing individualized responses, remain largely unknown. This trial examined gut microbiota (GM) and health outcomes in household dogs after synbiotic (SN) supplementation containing probiotics and inulin (a prebiotic). Healthy dogs were randomized to receive SN (50 mg/d inulin and 20 billion total CFU/d of L. reuteri, P. acidilactici, E. faecium, L. acidophilus, B. animalis, L. fermentum, L. rhamnosus) or placebo (PL) for 4 weeks. Owners completed a health survey and collected stool samples for GM profiling (shotgun metagenomic sequencing) at baseline and week 4 in both groups, and at week 6 in the SN group.ResultsA significant shift (p < 0.001) in β-diversity was observed in the SN (n = 24), but not PL group (n = 19), at week 4 relative to baseline. Forty-five bacterial species, 43 (96%) of which were Lactobacillales, showed an increase in the relative abundances (≥2 fold change, adjusted p < 0.05) in the SN group at week 4. E. coli also decreased at week 4 in the SN group (2.8-fold, adjusted p < 0.01). The altered taxa largely returned to baseline at week 6. The degree of changes in β-diversity was associated with GM at baseline. Specifically, dogs with higher Proteobacteria and lower Lactobacillales responded more robustly to supplementation in terms of the change in β-diversity. Dogs fed SN tended to have lower diarrhea incidence (0% vs 16%, p = 0.08).ConclusionsSN supplement had a short-term impact on the gut microbiota in healthy household dogs as characterized by shotgun metagenomic sequencing. Findings warrant further investigation with longer duration and populations at risk of gastrointestinal diseases. The magnitude of response to the supplement was associated with microbial profile at baseline. To our knowledge, this is the first study documenting such association and may provide a basis for personalized nutrition in companion dogs.

Highlights

  • Probiotics have been demonstrated to ameliorate clinical signs of gastrointestinal diseases in dogs in various studies

  • The underlying mechanisms of probiotic function rely on interactions between members of the gut microbiota (GM) and host cells

  • Seven dogs did not complete the study for the following reasons: vomiting and diarrhea 1 day prior to starting the supplement (n = 1); lost-to-follow-up (n = 6)

Read more

Summary

Introduction

Probiotics have been demonstrated to ameliorate clinical signs of gastrointestinal diseases in dogs in various studies. The effect of probiotics in a healthy population, as well as factors contributing individualized responses, remain largely unknown This trial examined gut microbiota (GM) and health outcomes in household dogs after synbiotic (SN) supplementation containing probiotics and inulin (a prebiotic). While clinical or biological outcomes were improved in these trials, changes in microbial composition were measured in only a limited number of studies [7, 13, 18,19,20] Most of these included dogs with varied severity and types of diarrhea with a primary aim to improve diarrhea symptoms [7, 13, 20], and gut dysbiosis was shown to be improved with probiotic supplementation [7, 13]

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call